{"id":1934,"date":"2025-09-07T11:35:34","date_gmt":"2025-09-07T11:35:34","guid":{"rendered":"https:\/\/readtrends.com\/en\/sucralose-arginine-immunotherapy\/"},"modified":"2025-09-07T11:35:34","modified_gmt":"2025-09-07T11:35:34","slug":"sucralose-arginine-immunotherapy","status":"publish","type":"post","link":"https:\/\/readtrends.com\/en\/sucralose-arginine-immunotherapy\/","title":{"rendered":"Arginine may reverse sucralose-linked immunotherapy failure"},"content":{"rendered":"<article>\n<p><time datetime=\"2025-09-06\">September 6, 2025<\/time> \u2014 Researchers at the University of Pittsburgh report that high sucralose intake altered the gut microbiome, reduced arginine levels and was associated with weaker responses to anti\u2011PD1 cancer immunotherapy; in mice, arginine or citrulline supplements restored treatment effectiveness.<\/p>\n<h2>Key Takeaways<\/h2>\n<ul>\n<li>Sucralose consumption shifted the gut microbiome toward arginine\u2011degrading bacteria in mice.<\/li>\n<li>Reduced arginine was measured in blood, tumor interstitial fluid and stool after sucralose exposure.<\/li>\n<li>Sucralose-fed mice showed poorer responses to anti\u2011PD1 immunotherapy and larger tumors.<\/li>\n<li>Supplementing arginine or citrulline in mice restored T cell function and immunotherapy efficacy.<\/li>\n<li>An observational analysis of 132 patients with advanced melanoma or non\u2011small cell lung cancer found worse outcomes among high sucralose consumers.<\/li>\n<li>Investigators propose clinical trials testing citrulline supplementation and plan to study other sweeteners.<\/li>\n<\/ul>\n<h2>Verified Facts<\/h2>\n<p>The study, published in Cancer Discovery (DOI: <a href=\"https:\/\/doi.org\/10.1158\/2159-8290.CD-25-0247\" target=\"_blank\" rel=\"noopener\">10.1158\/2159-8290.CD-25-0247<\/a>), combined mouse experiments and a retrospective patient analysis. In mice, dietary sucralose changed gut bacterial composition, favoring species that consume arginine and lowering arginine concentrations systemically and within tumors.<\/p>\n<p>Arginine is a key metabolite required for effective T cell responses. In preclinical models of adenocarcinoma and melanoma, mice fed sucralose experienced impaired T cell activity and reduced benefit from anti\u2011PD1 checkpoint inhibitors, producing larger tumors and shorter survival compared with controls.<\/p>\n<p>When researchers supplemented sucralose\u2011fed mice with either arginine or citrulline (a precursor that raises arginine levels), T cell function and anti\u2011PD1 efficacy were largely restored. The team reports measurements showing arginine increases in blood and tumor compartments after supplementation.<\/p>\n<p>To examine human relevance, the investigators analyzed diet questionnaires and outcomes for 132 patients with advanced melanoma or non\u2011small cell lung cancer treated with anti\u2011PD1 therapy (alone or with chemotherapy). Higher self\u2011reported sucralose use correlated with poorer responses and survival in this cohort.<\/p>\n<h2>Context &#038; Impact<\/h2>\n<p>Artificial sweeteners like sucralose are widely used by people managing weight or blood sugar; the new findings suggest they could unintentionally impair immunotherapy for some cancer patients by altering microbiome metabolism.<\/p>\n<p>If validated in controlled trials, a simple nutritional intervention \u2014 for example, citrulline supplements that efficiently raise arginine \u2014 could be offered to patients who continue to consume sucralose, avoiding the need for drastic diet changes during treatment.<\/p>\n<p>Beyond sucralose, the team intends to investigate whether other sugar substitutes (aspartame, saccharin, xylitol, stevia) affect the microbiome or immune responses to cancer therapy, broadening implications for dietary guidance in oncology.<\/p>\n<h2>Official Statements<\/h2>\n<blockquote>\n<p>&#8220;Arginine supplementation may offer a practical way to counteract sucralose\u2011driven immunotherapy resistance without forcing patients to overhaul their diets,&#8221;<\/p>\n<p>  <cite>Abby Overacre, Ph.D., University of Pittsburgh<\/cite>\n<\/p><\/blockquote>\n<aside>\n<details>\n<summary>Explainer: Why arginine matters for immunotherapy<\/summary>\n<p>Arginine is an amino acid that supports T cell proliferation, survival and effector function. When arginine availability falls, T cells show reduced activation and tumor\u2011killing capacity, which can blunt the effect of immune checkpoint inhibitors such as anti\u2011PD1 antibodies.<\/p>\n<\/details>\n<\/aside>\n<h2>Unconfirmed or Pending Questions<\/h2>\n<ul>\n<li>Human data are observational and based on self\u2011reported diet questionnaires; causality is not proven.<\/li>\n<li>The sucralose intake threshold that might affect therapy is not defined.<\/li>\n<li>Whether the same effect occurs with other sweeteners remains to be established.<\/li>\n<li>Optimal dosing, timing and safety of arginine or citrulline supplementation in cancer patients require clinical trials.<\/li>\n<\/ul>\n<h2>Bottom Line<\/h2>\n<p>This study identifies a microbiome\u2011mediated mechanism by which sucralose can lower arginine and compromise anti\u2011PD1 immunotherapy in mice and presents supportive, though observational, human associations; citrulline or arginine supplementation restored therapy efficacy in animals and now merit testing in clinical trials.<\/p>\n<h2>Sources<\/h2>\n<ul>\n<li><a href=\"https:\/\/www.sciencedaily.com\/releases\/2025\/09\/250906013455.htm\" target=\"_blank\" rel=\"noopener\">ScienceDaily \u2014 University of Pittsburgh press summary (Sep 6, 2025)<\/a><\/li>\n<li><a href=\"https:\/\/doi.org\/10.1158\/2159-8290.CD-25-0247\" target=\"_blank\" rel=\"noopener\">Cancer Discovery \u2014 Sucralose consumption ablates cancer immunotherapy response through microbiome disruption (DOI)<\/a><\/li>\n<li><a href=\"https:\/\/www.upmc.com\" target=\"_blank\" rel=\"noopener\">UPMC \/ University of Pittsburgh materials<\/a><\/li>\n<\/ul>\n<p>Funding acknowledgements reported by the authors include support from the National Institutes of Health, the Damon Runyon Cancer Research Foundation and Gateway for Cancer Research.<\/p>\n<\/article>\n","protected":false},"excerpt":{"rendered":"<p>September 6, 2025 \u2014 Researchers at the University of Pittsburgh report that high sucralose intake altered the gut microbiome, reduced arginine levels and was associated with weaker responses to anti\u2011PD1 cancer immunotherapy; in mice, arginine or citrulline supplements restored treatment effectiveness. Key Takeaways Sucralose consumption shifted the gut microbiome toward arginine\u2011degrading bacteria in mice. Reduced &#8230; <a title=\"Arginine may reverse sucralose-linked immunotherapy failure\" class=\"read-more\" href=\"https:\/\/readtrends.com\/en\/sucralose-arginine-immunotherapy\/\" aria-label=\"Read more about Arginine may reverse sucralose-linked immunotherapy failure\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":1931,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_title":"Arginine may restore immunotherapy after sucralose | HealthBrief","rank_math_description":"University of Pittsburgh researchers report sucralose can disrupt the microbiome and lower arginine, weakening anti\u2011PD1 immunotherapy; arginine or citrulline restored efficacy in mice and warrants clinical trials.","rank_math_focus_keyword":"sucralose, arginine, immunotherapy, microbiome, citrulline, anti-PD1","footnotes":""},"categories":[2],"tags":[],"class_list":["post-1934","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-top-stories"],"_links":{"self":[{"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/posts\/1934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/comments?post=1934"}],"version-history":[{"count":0,"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/posts\/1934\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/media\/1931"}],"wp:attachment":[{"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/media?parent=1934"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/categories?post=1934"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/readtrends.com\/en\/wp-json\/wp\/v2\/tags?post=1934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}